Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,272 | 79 | 97.7% |
| Education | $29.99 | 1 | 2.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | $263.24 | 14 | $0 (2023) |
| Allergan, Inc. | $132.71 | 8 | $0 (2020) |
| AbbVie Inc. | $127.80 | 7 | $0 (2023) |
| Amgen Inc. | $123.38 | 8 | $0 (2020) |
| Novo Nordisk Inc | $100.97 | 6 | $0 (2022) |
| AstraZeneca Pharmaceuticals LP | $82.86 | 6 | $0 (2022) |
| Merck Sharp & Dohme Corporation | $67.79 | 5 | $0 (2020) |
| Amarin Pharma Inc. | $40.53 | 2 | $0 (2019) |
| Lilly USA, LLC | $37.45 | 3 | $0 (2022) |
| PFIZER INC. | $37.40 | 3 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $30.98 | 1 | Averitas Pharma Inc. ($30.98) |
| 2023 | $86.78 | 4 | Boehringer Ingelheim Pharmaceuticals, Inc. ($38.18) |
| 2022 | $112.74 | 7 | ABBVIE INC. ($50.42) |
| 2021 | $79.45 | 4 | Boehringer Ingelheim Pharmaceuticals, Inc. ($67.76) |
| 2020 | $193.70 | 12 | Amgen Inc. ($66.84) |
| 2019 | $409.87 | 27 | Allergan Inc. ($73.22) |
| 2018 | $183.20 | 11 | Allergan Inc. ($45.85) |
| 2017 | $204.79 | 14 | Boehringer Ingelheim Pharmaceuticals, Inc. ($41.67) |
All Payment Transactions
80 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 08/29/2024 | Averitas Pharma Inc. | QUTENZA (Drug) | Food and Beverage | In-kind items and services | $30.98 | General |
| Category: PAIN MANAGEMENT | ||||||
| 03/28/2023 | Kowa Pharmaceuticals America, Inc. | SEGLENTIS (Drug), LIVALO | Food and Beverage | In-kind items and services | $13.86 | General |
| Category: PAIN MANAGEMENT | ||||||
| 03/06/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $20.08 | General |
| Category: DIABETES | ||||||
| 02/08/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | TRADJENTA (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $18.10 | General |
| Category: DIABETES | ||||||
| 01/12/2023 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $34.74 | General |
| Category: NEUROSCIENCE | ||||||
| 09/07/2022 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $15.50 | General |
| Category: NEUROSCIENCE | ||||||
| 08/22/2022 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $12.35 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 06/30/2022 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $13.98 | General |
| Category: Diabetes | ||||||
| 05/18/2022 | Kowa Pharmaceuticals America, Inc. | Livalo (Drug), Seglentis | Food and Beverage | Cash or cash equivalent | $13.26 | General |
| Category: Cardiovascular | ||||||
| 04/26/2022 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $12.67 | General |
| Category: NEUROSCIENCE | ||||||
| 01/27/2022 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $22.25 | General |
| Category: NEUROSCIENCE | ||||||
| 01/13/2022 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $22.73 | General |
| Category: Diabetes | ||||||
| 09/07/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $11.69 | General |
| Category: NEUROSCIENCE | ||||||
| 03/04/2021 | Boehringer Ingelheim Pharmaceuticals, Inc. | TRADJENTA (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $27.23 | General |
| Category: DIABETES | ||||||
| 02/08/2021 | Boehringer Ingelheim Pharmaceuticals, Inc. | TRADJENTA (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $25.94 | General |
| Category: DIABETES | ||||||
| 01/08/2021 | Boehringer Ingelheim Pharmaceuticals, Inc. | TRADJENTA (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $14.59 | General |
| Category: DIABETES | ||||||
| 09/16/2020 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $16.11 | General |
| Category: Bone Health | ||||||
| 08/03/2020 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $18.37 | General |
| Category: Bone Health | ||||||
| 07/21/2020 | Amgen Inc. | Aimovig (Biological), Otezla, Repatha | Food and Beverage | In-kind items and services | $16.84 | General |
| Category: Neuroscience | ||||||
| 07/17/2020 | Allergan, Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $13.64 | General |
| Category: NEUROSCIENCE | ||||||
| 07/08/2020 | Boehringer Ingelheim Pharmaceuticals, Inc. | TRADJENTA (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $17.97 | General |
| Category: DIABETES | ||||||
| 05/06/2020 | Amgen Inc. | Aimovig (Biological), Otezla, Repatha | Food and Beverage | In-kind items and services | $15.52 | General |
| Category: Neuroscience | ||||||
| 05/05/2020 | Boehringer Ingelheim Pharmaceuticals, Inc. | TRADJENTA (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $19.81 | General |
| Category: DIABETES | ||||||
| 03/31/2020 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $11.02 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 03/05/2020 | PFIZER INC. | CHANTIX (Drug), EUCRISA, COLOGUARD | Food and Beverage | In-kind items and services | $15.14 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 25 | 1,129 | 2,566 | $298,385 | $117,560 |
| 2022 | 35 | 3,816 | 7,278 | $332,963 | $202,416 |
| 2021 | 38 | 3,962 | 7,216 | $293,048 | $186,530 |
| 2020 | 40 | 4,104 | 6,776 | $269,124 | $158,716 |
All Medicare Procedures & Services
138 procedure records from CMS Medicare Utilization — Page 2 of 6
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 302 | 667 | $89,302 | $51,669 | 57.9% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 100 | 686 | $52,598 | $37,683 | 71.6% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 105 | 154 | $33,423 | $23,234 | 69.5% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 55 | 154 | $17,466 | $11,957 | 68.5% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2022 | 259 | 438 | $17,412 | $7,222 | 41.5% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2022 | 41 | 71 | $7,886 | $5,677 | 72.0% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2022 | 82 | 98 | $7,676 | $5,268 | 68.6% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2022 | 284 | 502 | $11,404 | $5,222 | 45.8% |
| 82607 | Cyanocobalamin (vitamin b-12) level | Office | 2022 | 245 | 350 | $6,785 | $5,118 | 75.4% |
| 82746 | Folic acid level, serum | Office | 2022 | 241 | 339 | $5,841 | $4,829 | 82.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 36 | 43 | $7,997 | $4,801 | 60.0% |
| 82306 | Vitamin d-3 level | Office | 2022 | 142 | 165 | $6,120 | $4,726 | 77.2% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2022 | 284 | 510 | $10,780 | $3,896 | 36.1% |
| 84439 | Thyroxine (thyroid chemical), free | Office | 2022 | 256 | 433 | $5,743 | $3,824 | 66.6% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2022 | 208 | 285 | $4,155 | $3,737 | 90.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 24 | 24 | $3,266 | $3,005 | 92.0% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 66 | 328 | $9,388 | $2,764 | 29.4% |
| 90674 | Influenza vaccine, quadrivalent derived from cell cultures, preservative and antibiotic free | Office | 2022 | 83 | 83 | $4,224 | $2,559 | 60.6% |
| 83036 | Hemoglobin a1c level | Office | 2022 | 167 | 254 | $3,186 | $2,382 | 74.7% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 83 | 83 | $3,296 | $2,187 | 66.4% |
| 81000 | Manual urinalysis test with examination using microscope, non-automated | Office | 2022 | 263 | 449 | $2,125 | $1,752 | 82.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 30 | 33 | $3,125 | $1,748 | 55.9% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2022 | 22 | 42 | $4,838 | $1,468 | 30.3% |
| 83735 | Magnesium level | Office | 2022 | 154 | 214 | $2,272 | $1,395 | 61.4% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2022 | 25 | 30 | $2,621 | $1,266 | 48.3% |
About Dr. Todd Smith, DO
Dr. Todd Smith, DO is a Internal Medicine healthcare provider based in Princeton, West Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/20/2006. The National Provider Identifier (NPI) number assigned to this provider is 1780649889.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Todd Smith, DO has received a total of $1,302 in payments from pharmaceutical and medical device companies, with $30.98 received in 2024. These payments were reported across 80 transactions from 23 companies. The most common payment nature is "Food and Beverage" ($1,272).
As a Medicare-enrolled provider, Smith has provided services to 13,011 Medicare beneficiaries, totaling 23,836 services with total Medicare billing of $665,222. Data is available for 4 years (2020–2023), covering 138 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Princeton, WV
- Active Since 04/20/2006
- Last Updated 07/10/2008
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1780649889
Products in Payments
- TRADJENTA (Drug) $175.95
- VRAYLAR (Drug) $105.16
- JARDIANCE (Drug) $97.06
- UBRELVY (Drug) $96.85
- FARXIGA (Drug) $82.86
- Aimovig (Biological) $49.84
- JANUVIA (Drug) $49.83
- Ozempic (Drug) $45.93
- Vascepa (Drug) $40.53
- Prolia (Biological) $39.06
- CHANTIX (Drug) $37.40
- EVENITY (Biological) $34.48
- Movantik (Drug) $34.00
- QUTENZA (Drug) $30.98
- Trintellix (Drug) $28.79
- LINZESS (Drug) $27.55
- Trulance (Drug) $24.76
- Rybelsus (Drug) $22.73
- Tresiba (Drug) $21.22
- FreeStyle Libre (Device) $19.85
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Princeton
Dr. Ryan Lang, M.d, M.D
Internal Medicine — Payments: $443,150
Dr. Constance Winslow, M.d, M.D
Internal Medicine — Payments: $308,350
Dr. Kent Allenby, M.d, M.D
Internal Medicine — Payments: $209,745
Dr. Louis Baxter, Md, MD
Internal Medicine — Payments: $195,825
Mr. Ernest De La Cruz, Md, MD
Internal Medicine — Payments: $12,435
Srinivas Mendu, M.d, M.D
Internal Medicine — Payments: $10,996